Cargando…
Systematic Analysis of Covalent and Allosteric Protein Kinase Inhibitors
In drug discovery, protein kinase inhibitors (PKIs) are intensely investigated as drug candidates in different therapeutic areas. While ATP site-directed, non-covalent PKIs have long been a focal point in protein kinase (PK) drug discovery, in recent years, there has been increasing interest in allo...
Autores principales: | Xerxa, Elena, Laufkötter, Oliver, Bajorath, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420927/ https://www.ncbi.nlm.nih.gov/pubmed/37570774 http://dx.doi.org/10.3390/molecules28155805 |
Ejemplares similares
-
Data sets of human and mouse protein kinase inhibitors with curated activity data including covalent inhibitors
por: Xerxa, Elena, et al.
Publicado: (2023) -
Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallography
por: Hu, Huabin, et al.
Publicado: (2021) -
Kinase inhibitor data set for systematic analysis of representative kinases across the human kinome
por: Laufkötter, Oliver, et al.
Publicado: (2020) -
Approach for the Design of Covalent Protein Kinase Inhibitors via Focused Deep Generative Modeling
por: Yoshimori, Atsushi, et al.
Publicado: (2022) -
Large-Scale Comparison of Alternative Similarity Search Strategies with Varying Chemical
Information Contents
por: Laufkötter, Oliver, et al.
Publicado: (2019)